CCR2 and lung carcinoma: Interestingly, chemotherapy including cisplatin has been shown to promote secretion of MCP-1, recruit inflammatory monocytes enriched with the receptor of MCP-1, CCR2, forming pre-metastatic niches, thus promoting distant metastasis in breast and lung cancer [50, 51].